Determinants of cervical cancer rates in developing countries
- PMID: 12115570
- DOI: 10.1002/ijc.10453
Determinants of cervical cancer rates in developing countries
Abstract
Although cervical cancer (CC) is a leading cause of cancer-related deaths in developing countries, incidence rates vary considerably, ranging from 3 to 61 per 10(5) females. Identifying determinants of high vs. low rates may suggest population-level prevention strategies. CC rates for 175 countries were obtained from the IARC. Country-specific behavioral, health, economic and demographic measures were obtained from United Nations agencies and other international organizations. Regression analyses performed for 127 low or medium developed countries identified both geography and religion as independently associated with high CC rates. Among behavioral measures, high fertility rates, early age at birth of first child and high teenage birth rates were significantly associated with high CC rates. Countries with high CC rates had fewer doctors per capita, less immunization coverage, more HIV infections and shorter life expectancies. CC rates also tended to be higher in countries with more spending on health and younger, less educated populations. Patterns of CC rates suggest that programmatic approaches, such as promoting delayed childbearing and sexual monogamy, may be appropriate interventions. For countries with high CC rates and some flexibility in their health-care budgets, a once-in-a-lifetime screen of women 30-50 years of age, using Pap smears, direct visual inspection and/or HPV DNA testing, may be cost-effective. Finally, relatively low immunization rates and a shortage of health-care workers in countries with high CC rates suggest potential challenges for introducing prophylactic HPV vaccines.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.Vaccine. 2013 Dec 29;31 Suppl 5:F60-72. doi: 10.1016/j.vaccine.2012.07.093. Vaccine. 2013. PMID: 24331749
-
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.Vaccine. 2008 Jul 29;26(32):4080-93. doi: 10.1016/j.vaccine.2008.04.053. Epub 2008 May 15. Vaccine. 2008. PMID: 18550229
-
The global impact of noncommunicable diseases: estimates and projections.World Health Stat Q. 1988;41(3-4):255-66. World Health Stat Q. 1988. PMID: 3232413
-
Implementation of human papillomavirus immunization in the developing world.Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Vaccine. 2012. PMID: 23199963 Review.
-
Socioeconomic status and cancer screening.IARC Sci Publ. 1997;(138):369-76. IARC Sci Publ. 1997. PMID: 9353678 Review.
Cited by
-
Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil.Mol Biol Rep. 2014 Feb;41(2):865-74. doi: 10.1007/s11033-013-2927-2. Epub 2014 Jan 7. Mol Biol Rep. 2014. PMID: 24395291
-
Vaginal Infections of Albanian women Infected with HPV and their impact in intraepithelial cervical lesions evidenced by Pap test.J Cytol. 2017 Jan-Mar;34(1):16-21. doi: 10.4103/0970-9371.197592. J Cytol. 2017. PMID: 28182076 Free PMC article.
-
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.Gynecol Oncol. 2006 Dec;103(3):1017-22. doi: 10.1016/j.ygyno.2006.06.015. Epub 2006 Jul 27. Gynecol Oncol. 2006. PMID: 16875716 Free PMC article.
-
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries.BMC Infect Dis. 2006 Nov 30;6:172. doi: 10.1186/1471-2334-6-172. BMC Infect Dis. 2006. PMID: 17137513 Free PMC article.
-
HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.Epidemics. 2010 Dec;2(4):173-82. doi: 10.1016/j.epidem.2010.08.003. Epub 2010 Sep 15. Epidemics. 2010. PMID: 21352788 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials